XML 49 R34.htm IDEA: XBRL DOCUMENT v3.22.4
SHAREHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Assumptions Used to Estimate Fair Value
   
Year ended December 31,
 
   
2022
   
2021
   
2020
 
                   
Risk free interest
 
1.41%-4.15%
 
 
0.26%-1.14%
 
 
-
 
Dividend yields
 
0%
 
 
0%
 
 
-
 
Volatility
 
51.45%-52.95%
 
 
41.09%-50.62%
 
 
-
 
Expected term (in years)
 
3.92-4.00
   
4.00-4.04
   
-
 
Schedule of Stock Option Activity
   
Number of
options
   
Weighted-
average
exercise price
*)
   
Weighted-
average
remaining
contractual
term
(in years)
   
Aggregate
intrinsic
value
(in thousands)
*)
 
                         
Outstanding at January 1, 2022
   
3,099,144
   
$
7.8
     
4.5
   
$
1,737
 
                                 
Granted
   
937,500
   
$
8.0
                 
Exercised
   
(235,000
)
 
$
5.7
                 
Forfeited and cancelled
   
(360,000
)
 
$
7.0
                 
                                 
Outstanding as of December 31, 2022
   
3,441,644
   
$
8.1
     
4.1
   
$
80
 
                                 
Exercisable as of December 31, 2022
   
728,727
   
$
7.8
     
2.7
   
$
80
 
Schedule of Stock-Based Compensation Expenses
   
Year ended December 31,
 
   
2022
   
2021
   
2020
 
                   
Cost of revenues of products
 
$
147
   
$
137
   
$
82
 
Cost of revenues of services
   
146
     
140
     
84
 
Research and development, net
   
427
     
304
     
279
 
Selling and marketing
   
456
     
422
     
287
 
General and administrative
   
1,044
     
301
     
550
 
                         
   
$
2,220
   
$
1,304
   
$
1,282